Touyun Biotech Group (HKSE:01332) Total Liabilities: HK$592.31 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01332 Touyun Biotech Group Ltd HKSE:01332
20 GF Score
Price HK$0.15
GF Value HK$0.16
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Touyun Biotech Group Total Liabilities?

Touyun Biotech Group HKSE:01332 +5.71% 20 Total Liabilities is HK$592.31 Mil as of Dec. 2025. GuruFocus rates HKSE:01332 with a GF Score™ of 20/100 and a GF Value™ of HK$0.16 (Fairly Valued). The stock has 6 warning signs investors should review.

Touyun Biotech Group's Total Liabilities for the quarter that ended in Dec. 2025 was HK$592.31 Mil.

Touyun Biotech Group's quarterly Total Liabilities increased from Dec. 2024 (HK$590.96 Mil) to Jun. 2025 (HK$619.38 Mil) but then declined from Jun. 2025 (HK$619.38 Mil) to Dec. 2025 (HK$592.31 Mil).

Touyun Biotech Group's annual Total Liabilities increased from Dec. 2023 (HK$586.27 Mil) to Dec. 2024 (HK$590.96 Mil) and increased from Dec. 2024 (HK$590.96 Mil) to Dec. 2025 (HK$592.31 Mil).

Touyun Biotech Group Total Liabilities Historical Data

* Premium members only.

The historical data trend for Touyun Biotech Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Touyun Biotech Group Total Liabilities Chart

Touyun Biotech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 537.68 604.19 586.27 590.96 592.31

Touyun Biotech Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 586.27 597.42 590.96 619.38 592.31
HKSE:01332
20GF Score
Touyun Biotech Group Ltd HKSE:01332
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Touyun Biotech Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Touyun Biotech Group's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=591.449+(0.353+3.2751579226442E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0.511)
=592.31

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=619.704-27.391
=592.31

Touyun Biotech Group's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=591.449+(0.353+3.2751579226442E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0.511)
=592.31

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=619.704-27.391
=592.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of HK$592.31 Mil mean?
Touyun Biotech Group (HKSE:01332) has a Total Liabilities of HK$592.31 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Touyun Biotech Group and its competitors.
Is Touyun Biotech Group's Total Liabilities too high?
Touyun Biotech Group's current Total Liabilities is HK$592.31 Mil. Overall, Touyun Biotech Group has a GF Score™ of 20/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's Total Liabilities compare to SW and PKG?
Touyun Biotech Group's Total Liabilities of HK$592.31 Mil can be compared against companies in the Packaging & Containers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Packaging & Containers company?
A good Total Liabilities depends on the Packaging & Containers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Touyun Biotech Group and its competitors. Touyun Biotech Group's current Total Liabilities is HK$592.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.15 — trading 7.5% below its estimated fair value. The current Total Liabilities is HK$592.31 Mil. Touyun Biotech Group's overall GF Score™ is 20/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current Total Liabilities is HK$592.31 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?

Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued. The current stock price of HK$0.15 is trading 7.5% below its estimated GF Value™ of HK$0.16. GuruFocus considers Touyun Biotech Group to be Fairly Valued.

Key valuation signals for HKSE:01332:

  • Total Liabilities: HK$592.31 Mil
  • GF Value™: HK$0.16 vs. price of HK$0.15 (7.5% below fair value)
  • GF Score™: 20/100 with 6 warning signs

No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Touyun Biotech Group Business Description

Address 6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
20GF Score

Get the complete analysis for HKSE:01332

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.15
Price
HK$0.16
GF Value